Close Menu

NEW YORK – Becton Dickinson reported an 11 percent year-over-year decrease in its fiscal third quarter revenues on Thursday due to impacts of the ongoing COVID-19 pandemic.

For the three months ended June 30, the medical technology company posted $3.86 billion in revenues, down from $4.35 billion in the year-ago quarter and below the average analyst estimates of $3.94 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.